Select a Company
11.25 NGN 0 / 0%
As of 24-Mar-2025
Me Cure Industries Plc
Health Care Pharmaceuticals & Biotechnology11.25 NGN 0 / 0%
As of 24-Mar-2025
Prev. Close
11.25
Volume
31,700
Turnover
NGN 337,340.00
Deals
5
Shares Outstanding
4,000.00 mln
Market Cap.
NGN 45,000.00 mln
Loading Chart ...
52W RANGE
7.35 - 13.90
1W
--
1M
-10.36%
3M
-1.75%
YTD
-19.06%
1Y
+15.74%
Profile
Announcements
News
Reports
Dividends
About the company
Me Cure is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. For more than a decade, the company has tapped the power of new technology and innovation to advance the practice of medicine. Products: OTC Medicines, Branded Generics and Dietary Supplements.
Website
www.mecure.com
info@mecure.com
Website
www.mecure.com
info@mecure.com
| SYMBOL MECURE |
ISIN NGMECURE0006 |
| Founded 2005 |
Listed 2023 |
| Phone - |
FAX - |
Me Cure House, Plot 6, Block H, Apapa Oshodi Expressway, Oshodi, Lagos. Nigeria |
|
Competitors
| Fidson Healthcare Plc | 18.90 | -- |
| Neimeth International Pharmaceuticals Plc | 3.00 | -- |
| Juli Plc | 10.30 | -- |
| Pharma-Deko Plc | 1.83 | -- |
| May & Baker Nigeria Plc | 8.00 | -- |
| MECURE | Declaration of dividend | 4 Mar. 2025 |
| MECURE | Notice of board meeting | 14 Feb. 2025 |
| MECURE | Notice of closed period | 6 Jan. 2025 |
| MECURE | Share dealing | 8 Nov. 2024 |
| MECURE | Share dealing | 8 Nov. 2024 |
| MECURE | Notice of board meeting | 23 Oct. 2024 |
| MECURE | Acquisition of ten Percent Equity Stake | 6 Oct. 2024 |
| MECURE | Notice of board meeting | 5 Aug. 2024 |
| MECURE | AGM resolutions | 8 Jul. 2024 |
| MECURE | Notice of annual general meeting | 6 Jun. 2024 |
| MECURE | Appointment of independent directors | 16 May. 2024 |
| MECURE | Correction of 2023 AFS | 29 Apr. 2024 |
| MECURE | Declaration of dividend | 6 Mar. 2024 |
| MECURE | Rescheduled of board meeting | 27 Feb. 2024 |
| MECURE | Notice of board meeting | 15 Feb. 2024 |
Research & Analysis
Annual & Financials Reports
| Annual Report | 2023 |
| Annual Report | 2022 |
| Annual Report | 2021 |
| Annual Report | 2020 |
| Annual Report | 2019 |
| Annual Report | 2018 |
| 0.15 NGN | 3 Jul. 2024 |
